| 摘要 |
The invention relates to the use of a 3-deoxyanthocyanidin of formula (I) in which R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and X- are as defined in the claims, with the condition that at least one of R1, R2, R3, R4 or R5 is a hydroxyl and at least one of R8, R9, R10 or R11 is a hydroxyl, for the treatment, prevention and/or stabilisation of ARMD, Stargardt disease, pigmentary retinopathy and/or diabetic retinopathy. |
| 申请人 |
BIOPHYTIS;UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS 6 (UPMC);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) |
发明人 |
FONTAINE, Valérie;LAFONT, René;SAHEL, José-Alain;VEILLET, Stanislas |
